Article

State of Science Summit- Leukemia/Lymphoma Chaired by Sergio Giralt, MD

In Partnership With:

State of Science Summit- Leukemia/Lymphoma Chaired by Sergio Giralt, MD

State of Science Summit- Leukemia/Lymphoma Chaired by Sergio Giralt, MD

Speakers

  • Eytan Stein, MD | Memorial Sloan Kettering Cancer Center
  • Lindsey Roeker, MD | Memorial Sloan Kettering Cancer Center
  • Zachary Epstein-Peterson, MD | Memorial Sloan Kettering Cancer Center
  • Raajit Rampal, MD, PhD | Memorial Sloan Kettering Cancer Center
  • Sergio Giralt, MD | Memorial Sloan Kettering Cancer Center

Topics

  • Recent Updates in AML
  • Role of BTKi in CLL
  • Management of MCL
  • Myelofibrosis Therapies
  • Myeloma and Transplant

Interested in attending a live or virtual event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science Summits. Click here to listen to our latest episodes!

Clinicians referring a patient to MSK can do so by visiting msk.org/refer, emailing referapatient@mskcc.org, or by calling 833-315-2722.
Related Videos
Areej El-Jawahri, MD, associate director, Cancer Outcomes Research and Education Program, director, Bone Marrow Transplant Survivorship Program, associate professor, medicine, Massachusetts General Hospital
Shyam A. Patel, MD, PhD
Amitkumar Mehta, MD
Grzegorz S. Nowakowski, MD
John Seymour, MBBS, FRACP, PhD
Reid Merryman, MD
Partow Kebriaei, MD
Jean L. Koff, MD, MS
Sonali M. Smith, MD
Sergio A. Giralt, MD
Related Content
Shyam A. Patel, MD,PhD
September 27th 2024

Meta-Analysis Reveals Potential Role of Clonal Hematopoiesis on Allogeneic and Autologous HSCT Outcomes

Komal Jhaveri, MD, FACP, section head, Endocrine Therapy Research Program, clinical director, Early Drug Development Service, Patricia and James Cayne Chair for Junior Faculty, Memorial Sloan Kettering Cancer Center
August 22nd 2024

Jhaveri on the INAVO120 Trial of Inavolisib/Palbociclib/Fulvestrant in PIK3CA -Mutant, HR+ Breast Cancer

Alexander Drilon, MD, of Memorial Sloan Kettering Cancer Center
September 14th 2024

NVL-655 Shows Strong Efficacy in Heavily Pretreated ALK+ NSCLC

Nam Bui, MD, sarcoma specialist, clinical assistant professor, medicine, Stanford Cancer Institute; Ciara Kelly, MBBCh, BAO, interim clinical director, Sarcoma Oncology Service, Memorial Sloan Kettering Cancer Center
July 18th 2024

Bui and Kelly Discuss the Utility of Nab-Sirolimus in Advanced Malignant PEComa

Michael Marrone, PhD, MPH
September 10th 2024

Real-World Data for Pacritinib Show Improvement in Thrombocytopenia, Anemia in Myelofibrosis

Charles M. Rudin, MD, PhD
September 7th 2024

Ifinatamab Deruxtecan Shows Improved Clinical Activity at Higher Dose in ES-SCLC